ArticleThe Journal of biological chemistry2026
F-actin-dependent activation of NADPH oxidase 5 by the vacuolar-type ATPase.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
NADPH oxidase 5 (NOX5) is a transmembrane oxidative signaling enzyme that produces superoxide in response to increases in intracellular calcium. NOX5 has been shown to play essential roles in processes such as specialized cell differentiation, proliferation, and cell contraction, while its overexpression and hyperactivation are associated with human diseases, including cardiovascular disorders, cancer, and diabetic kidney disease. Despite its importance in human health and disease, the regulatory factors and mechanistic signaling details of NOX5 remain incompletely resolved. We previously reported that chemical stabilization of F-actin by jasplakinolide induces a superoxide burst by NOX5 independent of changes in intracellular calcium. Here, we show that this F-actin-dependent activation of NOX5 superoxide production relies on the vacuolar-type ATPase (v-ATPase). In cells, jasplakinolide treatment stabilizes a complex comprising actin, actin-binding proteins, the v-ATPase, and NOX5. Chemical inhibition of the v-ATPase or v-ATPase subunit knockdown decreases NOX5 superoxide production in response to jasplakinolide while only minimally affecting NOX5 superoxide production in response to increases in intracellular calcium or NOX5 phosphorylation. Finally, in untreated cells, the v-ATPase and NOX5 localize to the cell leading edge and contribute to cell migration. Our findings represent a novel mechanism of NOX5-mediated superoxide production by the v-ATPase and provide a new foundation for developing strategies to disrupt protein interactions and activities that drive aberrant cell migration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.